Quest Diagnostics Incorporated (DGX) financial statements (2022 and earlier)

Company profile

Business Address 500 PLAZA DRIVE
SECAUCUS, NJ 07094
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8721,1581,192135195410182
Cash and cash equivalents8721,1581,192135137359133
Short-term investments    585149
Receivables1,4381,5201,0631,012924926901
Inventory, net of allowances, customer advances and progress billings20822312399958284
Inventory20822312399958284
Prepaid expense362314371441
Disposal group, including discontinued operation     9176
Other undisclosed current assets1871551091305590117
Total current assets:2,7413,0582,4901,3901,3061,5311,501
Noncurrent Assets
Operating lease, right-of-use asset597604518
Property, plant and equipment1,7071,6271,4531,2881,1451,029925
Long-term investments and receivables141521482436462443473
Long-term investments141521482436462443473
Intangible assets, net (including goodwill)8,2628,0407,7407,7707,4546,9496,889
Goodwill7,0956,8736,6196,5636,3356,0005,905
Intangible assets, net (excluding goodwill)1,1671,1671,1211,2071,119949984
Other noncurrent assets163176160119136148174
Total noncurrent assets:10,87010,96810,3539,6139,1978,5698,461
TOTAL ASSETS:13,61114,02612,84311,00310,50310,1009,962
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,6001,6331,0411,0211,0219751,014
Accounts payable357446263222224261279
Accrued liabilities460356223274246254257
Employee-related liabilities518502287249325316305
Taxes payable10432717934
Interest and dividends payable100102116118107108107
Other undisclosed accounts payable and accrued liabilities1551841251411103362
Debt44949464366159
Other undisclosed current liabilities149139     
Total current liabilities:1,7531,7761,9901,4851,0579811,173
Noncurrent Liabilities
Long-term debt and lease obligation, including:4,0104,0133,9663,4293,7483,7283,492
Long-term debt, excluding current maturities4,0104,0133,9663,4293,7483,7283,492
Finance lease, liability322530
Operating lease, liability494499413
Other undisclosed long-term debt and lease obligation(526)(524)(443)    
Liabilities, other than long-term debt792847711745663654514
Other liabilities792847711745663654514
Other undisclosed noncurrent liabilities494499413    
Total noncurrent liabilities:5,2965,3595,0904,1744,4114,3824,006
Total liabilities:7,0497,1357,0805,6595,4685,3635,179
Temporary equity, carrying amount79827677807770
Stockholders' equity
Stockholders' equity attributable to parent6,4446,7595,6415,2164,9214,6284,684
Common stock2222222
Treasury stock, value(3,453)(5,366)(5,218)(4,996)(4,783)(4,460)(3,960)
Additional paid in capital2,2602,8412,7222,6672,6122,5452,481
Accumulated other comprehensive loss(14)(21)(39)(59)(48)(72)(38)
Retained earnings7,6499,3038,1747,6027,1386,6136,199
Stockholders' equity attributable to noncontrolling interest39504651343229
Total stockholders' equity:6,4836,8095,6875,2674,9554,6604,713
TOTAL LIABILITIES AND EQUITY:13,61114,02612,84311,00310,50310,1009,962

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues10,7889,4377,7267,5317,7097,5157,493
Revenue, net7,5317,7097,5157,493
Cost of revenue(6,579)(5,804)(5,037)(4,926)(4,719)(4,616)(4,657)
Gross profit:4,2093,6332,6892,6052,9902,8992,836
Operating expenses(1,830)(1,653)(1,553)(1,518)(1,824)(1,635)(1,426)
Other operating income (expense), net2(9)9514(1)13(11)
Operating income:2,3811,9711,2311,1011,1651,2771,399
Nonoperating income (expense)218(87)(155)(175)(135)(191)(296)
Other nonoperating income (expense)3697620(8)16(48)(143)
Interest and debt expense(152)(166)(180)(169)(153)(144) 
Other undisclosed income from continuing operations before equity method investments, income taxes152166180169153144 
Income from continuing operations before equity method investments, income taxes:2,5991,8841,0769261,0301,0861,103
Income from equity method investments78755744353923
Income from continuing operations before income taxes:2,6771,9591,1339701,0651,1251,126
Income tax expense(597)(460)(247)(182)(241)(429)(373)
Income from continuing operations:2,0801,499886788824696753
Income from discontinued operations  20    
Net income:2,0801,499906788824696753
Net loss attributable to noncontrolling interest(85)(68)(48)(52)(52)(51)(44)
Net income attributable to parent:1,9951,431858736772645709
Other undisclosed net loss available to common stockholders, basic   (3)(3)(3) 
Net income available to common stockholders, diluted:1,9951,431858733769642709

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:2,0801,499906788824696753
Other comprehensive income (loss)71820(9)24(34)(11)
Comprehensive income:2,0871,517926779848662742
Comprehensive loss, net of tax, attributable to noncontrolling interest(85)(68)(48)(52)(52)(51)(44)
Comprehensive income, net of tax, attributable to parent:2,0021,449878727796611698

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: